NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS) is a one-stop access portal for Alzheimer's disease genetics and serves as the data coordinating center for the Alzheimer's Disease Sequencing Project (ADSP). ADSP has expanded substantially since NIAGADS submitted the renewal application in 2016, including processing sequence data of up to 114,335 genomes from 119 cohorts (10 times what was anticipated initially) and three new major initiatives on machine learning analysis, phenotype harmonization, and functional genomics. Neither NIA nor NIAGADS could have anticipated the major growth or the new NIA initiatives when the original application was written, and it is imperative that we augment the capacity of NIAGADS to maintain efficient operations with this supplement request. The proposed administrative supplement aims to augment the capacity of NIAGADS and maintain efficient operations for ADSP support in order that NIA meets its NAPA Milestones. The request is within the scope of the original research plan and includes four tasks: (1) additional programmer support to maintain NIAGADS cloud data sharing service and its security; (2) develop tools for cloud- based data analysis; (3) collaborate with Case Western Reserve University to enhance our cloud-based computing infrastructure for ADSP data analysis; (4) expand NIAGADS outreach with a website for disseminating AD genetics research to a wider audience.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
3U24AG041689-09S1
Application #
10162734
Study Section
Neuroscience of Aging Review Committee (NIA)
Program Officer
Yao, Alison Q
Project Start
2012-04-01
Project End
2022-03-31
Budget Start
2020-08-01
Budget End
2021-03-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Raghavan, Neha S; Brickman, Adam M; Andrews, Howard et al. (2018) Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease. Ann Clin Transl Neurol 5:832-842
Lobach, Iryna; Sampson, Joshua; Alekseyenko, Alexander et al. (2018) Case-control studies of gene-environment interactions. When a case might not be the case. PLoS One 13:e0201140
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Guerreiro, R; Orme, T; Naj, A C et al. (2018) Is APOE ?4 required for Alzheimer's disease to develop in TREM2 p.R47H variant carriers? Neuropathol Appl Neurobiol :
Blue, E E; Yu, C-E; Thornton, T A et al. (2018) Variants regulating ZBTB4 are associated with age-at-onset of Alzheimer's disease. Genes Brain Behav 17:e12429
Lobach, Iryna (2018) Bias in parameter estimates due to omitting gene-environment interaction terms in case-control studies. Genet Epidemiol 42:838-845
Deming, Yuetiva; Li, Zeran; Kapoor, Manav et al. (2017) Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. Acta Neuropathol 133:839-856
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384

Showing the most recent 10 out of 33 publications